Patrick A Flume Selected Research

Hemoptysis

10/2021	Pulmonary Complications in Cystic Fibrosis: Past, Present, and Future: Adult Cystic Fibrosis Series.
7/2011	Pneumothorax in cystic fibrosis.
8/2010	Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax.
5/2009	Pulmonary complications of cystic fibrosis.
8/2005	Pneumothorax in cystic fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrick A Flume Research Topics

Disease

44	Cystic Fibrosis (Mucoviscidosis) 04/2022 - 01/2004
11	Lung Diseases (Lung Disease) 03/2022 - 11/2007
11	Infections 01/2021 - 08/2010
5	Hemoptysis 10/2021 - 08/2005
5	Pneumothorax 10/2021 - 08/2005
5	Bronchiectasis 01/2018 - 01/2008
3	Persistent Infection 01/2018 - 12/2004
2	COVID-19 06/2021 - 01/2021
2	Pseudomonas Infections 01/2021 - 01/2011
2	Respiratory Tract Infections (Respiratory Tract Infection) 11/2016 - 07/2006
2	Cough 03/2015 - 01/2011
1	Pulmonary Tuberculosis 03/2022
1	Obesity 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 10/2021
1	Ototoxicity 01/2021
1	Dizziness (Lightheadedness) 01/2021
1	Tinnitus 01/2021
1	Vertigo (Positional Vertigo) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Hearing Loss (Hearing Impairment) 01/2021
1	Inflammation (Inflammations) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Superior Vena Cava Syndrome (Superior Vena Cava Obstruction) 07/2006
1	Thrombosis (Thrombus) 07/2006
1	Exocrine Pancreatic Insufficiency 08/2005
1	Allergic Bronchopulmonary Aspergillosis 08/2005
1	Bacterial Infections (Bacterial Infection) 12/2004
1	Body Weight (Weight, Body) 01/2004

Drug/Important Bio-Agent (IBA)

13	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 07/2006
6	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2022 - 09/2012
6	Levofloxacin (Levaquin)FDA Link 01/2021 - 06/2011
6	SolutionsIBA 01/2016 - 01/2011
5	Amikacin (A.M.K)FDA LinkGeneric 03/2022 - 01/2017
5	ivacaftorIBA 01/2022 - 09/2012
5	PowdersIBA 11/2021 - 01/2011
5	Tobramycin (Nebcin)FDA LinkGeneric 01/2021 - 05/2009
4	Liposomes (Liposome)IBA 03/2022 - 12/2018
4	SuspensionsIBA 03/2022 - 12/2018
4	Mannitol (Osmitrol)FDA LinkGeneric 11/2021 - 03/2012
3	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2018
2	EnzymesIBA 04/2022 - 01/2022
2	ivacaftor drug combination tezacaftorIBA 01/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 05/2017 - 01/2011
1	thiamine triphosphorate (TTP)IBA 03/2022
1	Culture MediaIBA 03/2022
1	Immunoglobulin G (IgG)IBA 06/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	AminoglycosidesIBA 01/2021
1	SphingolipidsIBA 01/2021
1	SphingosineIBA 01/2021
1	cavosonstatIBA 05/2017
1	Bronchodilator Agents (Bronchodilators)IBA 01/2017
1	FluoroquinolonesIBA 01/2016
1	ChloridesIBA 07/2015
1	lumacaftorIBA 01/2015
1	AerosolsIBA 06/2011
1	dornase alfa (Pulmozyme)FDA Link 05/2009
1	Linezolid (Zyvox)FDA Link 01/2004

Therapy/Procedure

23	Therapeutics 03/2022 - 12/2004
2	Enteral Nutrition (Feeding, Tube) 04/2022 - 08/2005
2	Lung Transplantation 01/2018 - 11/2007
1	Operative Surgical Procedures 01/2022
1	Dry Powder Inhalers 11/2021
1	Aftercare (After-Treatment) 01/2021
1	Terminal Care (Care, Terminal) 01/2018
1	Mechanical Ventilators (Ventilator) 05/2015
1	Topical Administration 05/2015
1	Vascular Access Devices (Arterial Line) 07/2006
1	Catheters 07/2006
1	Nebulizers and Vaporizers (Inhaler) 12/2004